CClinicalTrials.gg
CompletedNCT06389396Updated Jun 12, 2025Results posted

Investigation of a New Rectal Catheter for Users of Transanal Irrigation

An interventional study of CP362 Test Catheter in Bowel Management, sponsored by Coloplast A/S. Completed at 2 sites in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-06-12.

Sponsored by Coloplast A/S · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The clinical investigation is an exploratory, randomised controlled, open-labelled, crossover investigation.

The clinical investigation will be conducted as a multi-centre clinical investigation in two different clinical investigation sites in Denmark.

02

Conditions studied

  • Bowel Management
03

In context

Lead sponsor

Coloplast A/S is the lead sponsor of 146 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Has given written Informed Consent
  2. Is at least 18 years old
  3. Has full legal capacity
  4. Has used Trans Anal Irrigation (TAI) with balloon catheter for at least 4 weeks prior to inclusion
  5. Performs TAI minimum 3 times/week
  6. Is able to follow study procedures assessed by investigator

Exclusion criteria

Exclusion Criteria:

  1. Has known anal or colorectal stenosis
  2. Has active/recurrent colorectal cancer
  3. Is within 3 months of anal or colorectal surgery
  4. Is within 4 weeks of endoscopic polypectomy
  5. Has ischaemic colitis
  6. Has acute inflammatory bowel disease
  7. Has acute diverticulitis
  8. Is participating in any other clinical study that may interfere with this study (assessed by investigator).
  9. Is pregnant or breastfeeding
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    Investigational device - newly developed TAI catheter.

    CP362 Test Catheter: The investigational device is intended to perform TAI procedures together with the CE-marked Peristeen® Plus TAI system.

    Device: CP362 Test Catheter

  • No intervention
    Peristeen Plus

    Comparator catheter: The Peristeen® Plus rectal balloon catheter is used together with the CE-marked Peristeen® Plus TAI system.

Interventions

  • DeviceCP362 Test Catheter

    The investigational device is intended to perform TAI procedures together with the CE-marked Peristeen Plus TAI system.

06

What researchers measure

Primary outcomes

  1. Was it Possible to Perform Transanal Irrigation?

    After visit 1 and visit 2, the primary endpoint, defined as if it was possible to perform transanal irrigation, was answered by a yes/no answer.

    Time frame: Evaluated at Visit 1 and Visit 2 (within a time duration of up to 17 days)

07

Results

Posted Jun 12, 2025

Participant flow

Between April 2024 and July 2024, 20 users were recruited for the study from two sites and encompassed the Intention to treat (ITT) population.

Visit 1
Participant flow — Visit 1
MilestoneInvestigational Device Then Comparator DeviceComparator Device Then Investigational Device
Started1010
Completed1010
Not completed00
Visit 2
Participant flow — Visit 2
MilestoneInvestigational Device Then Comparator DeviceComparator Device Then Investigational Device
Started1010
Completed1010
Not completed00

Outcome measures

PrimaryWas it Possible to Perform Transanal Irrigation?

After visit 1 and visit 2, the primary endpoint, defined as if it was possible to perform transanal irrigation, was answered by a yes/no answer.

Time frame:
Evaluated at Visit 1 and Visit 2 (within a time duration of up to 17 days)
Reported as:
Number · Number of participants who replied YES
Was it Possible to Perform Transanal Irrigation?
Number of participants who replied YESInvestigational Device - Newly Developed TAI Catheter.Comparator Device - Peristeen Plus
Was it Possible to Perform Transanal Irrigation?2020

Adverse events

Collected over Adverse events were registered from the individual's enrolment until termination in the study. The total study duration for the individual subject was between two to 17 days, consisting of three site visits (V0-V2), where V0 and V1 could be performed the same day.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Investigational Device - Newly Developed TAI Catheter.0/20 (0%)0/20 (0%)0/20 (0%)
Comparator Catheter - Peristeen Plus0/20 (0%)0/20 (0%)0/20 (0%)

Baseline characteristics

\[Not Specified\]

Age, Continuous
Age, Continuous(years)Total ITT Population
Mean61 ± 11.3
Sex: Female, Male
Sex: Female, Male(Participants)Total ITT Population
Female15
Male5
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Total ITT Population
Region of Enrollment
Region of Enrollment(participants)Total ITT Population
Denmark20
08

Study locations

2 sites
  • Århus Universitetshospital
    Århus, Jutland 8200, Denmark
  • Amager Hvidovre Hospital
    Hvidovre, Zealand 2650, Denmark
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Apr 5, 2024

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 12, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT06389396
Lead sponsor
Coloplast A/S
Responsible party
Sponsor
First posted
Apr 29, 2024
Start date
Apr 8, 2024
Primary completion
Jul 30, 2024
Completion
Jul 30, 2024
Results posted
Jun 12, 2025
Last update
Jun 12, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion